У нас вы можете посмотреть бесплатно Abiraterone: A New Therapy for Metastatic Prostate Cancer | Memorial Sloan Kettering или скачать в максимальном доступном качестве, которое было загружено на ютуб. Для скачивания выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса savevideohd.ru
On April 28, 2011, the US Food and Drug Administration approved abiraterone acetate (Zytiga) in combination with prednisone for the treatment of metastatic, advanced prostate cancer in men who have received prior chemotherapy. Howard I. Scher, Chief of Memorial Sloan-Kettering's Genitourinary Oncology Service, was one of the principal investigators of the international clinical trials leading to the drug's approval. His colleagues at Memorial Sloan-Kettering also played a critical role in the research. Abiraterone is a pill taken once a day and will add to a growing arsenal of drugs to treat advanced prostate cancer. Dr. Scher sat down with us to answer some key questions about the new drug, how it works, and how it will impact the treatment of men with advanced prostate cancer. Learn about MSK: https://www.mskcc.org CONNECT WITH MSK Facebook: / sloankettering Twitter: / sloan_kettering Instagram: / sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/re...